Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
FOXP3-expressing T regulatory cells (Tregs) can be divided into two distinct subsets: naturally occurring Tregs (nTregs) that develop in the thymus, and induced Tregs (iTregs) that differentiate in peripheral tissues upon exposure to Ag in a tolerogenic environment. Recently it has been proposed that expression of Helios, an Ikaros family transcription factor, may specifically identify nTregs, allowing specific tracking of Tregs from different origins in health and disease. Surprisingly, we found that Helios- cells can be readily identified within naive (CD45RA+CD31+CCR7+CD62L+) FOXP3+ Tregs, a finding inconsistent with the notion that lack of Helios expression identifies Ag-experienced iTregs that should express memory markers. To investigate the phenotype and function of naive Helios+ and Helios− Tregs within the nTreg population, we isolated single-cell clones from each subset. We found that both Helios+ and Helios− nTreg clones have a similar suppressive capacity, as well as expression of FOXP3 and cell surface proteins, including CD39 and CTLA-4. Helios− nTregs, however, produced significantly more CCL3 and IFN-γ compared with Helios+ nTregs. Despite increased cytokine/chemokine production, Helios− FOXP3+ nTreg clones were demethylated at the FOXP3 Treg-specific demethylated region, indicative of Treg lineage stability. When cultured under Th1-polarizing conditions, Helios+ and Helios− nTreg clones had an equal ability to produce IFN-γ. Collectively, these data show that a lack of Helios expression does not exclusively identify human iTregs, and, to our knowledge, the data provide the first evidence for the coexistence of Helios+ and Helios− nTregs in human peripheral blood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, the expression of Helios is used to distinguish natural and peripheral induced Treg cells, that developed in the thymus or periphery, respectively, but this model is controversial in humans [173].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [173]
In the citing paper
“In humans, however, the validity of these markers is less clear because not all naive/thymus-derived Tregs express Helios [173] and it has been reported that this protein can also be expressed by activated T cells [366].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [173]
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“Because coexpression of the lymph node homing markers CCR7 and CD62L on CD45RA cells effectively differentiates naive T cells from memory T cells (25), we”
BackgroundA Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., & Campbell, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1731 · Cited by 1,258
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.002 · Cited by 1,055
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Self-citation
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
Self-citationSyed, A., Garcia, M. A., Lyu, S.-C., Bucayu, R., Kohli, A., Ishida, S., Berglund, J. P., Tsai, M., Maecker, H., O’Riordan, G., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1037 · Cited by 490
Regulation of Adaptive Immunity; The Role of Interleukin-10
Ng, T. H. S., Britton, G. J., Hill, E. V., Verhagen, J., Burton, B. R., & Wraith, D. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00129 · Cited by 354
Plasticity of Human CD4 T Cell Subsets
Geginat, J., Paroni, M., Maglie, S., Alfen, J. S., Kastirr, I., Gruarin, P., De Simone, M., Pagani, M., & Abrignani, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00630 · Cited by 292
FOXP3+ regulatory T cells and their functional regulation
Li, Z., Li, D., Tsun, A., & Li, B. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.10 · Cited by 290
Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
Yadav, M., Stephan, S., & Bluestone, J. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00232 · Cited by 273
Th17 plasticity and its relevance to inflammatory bowel disease
Ueno, A., Jeffery, L., Kobayashi, T., Hibi, T., Ghosh, S., & Jijon, H. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.004 · Cited by 266
Neuropilin 1: function and therapeutic potential in cancer
Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1500-0 · Cited by 233
“A recent study reported that both Helios+ and Helios− cells are found within the human tTreg population [76].”
BackgroundTREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214
Santegoets, S. J. A. M., Dijkgraaf, E. M., Battaglia, A., Beckhove, P., Britten, C. M., Gallimore, A., Godkin, A., Gouttefangeas, C., de Gruijl, T. D., Koenen, H. J. P. M., et al. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1729-x · Cited by 211
Thornton, A. M., Lu, J., Korty, P. E., Kim, Y. C., Martens, C., Sun, P. D., & Shevach, E. M. (2019) · European Journal of Immunology · doi:10.1002/eji.201847935 · Cited by 203
Treating Atherosclerosis With Regulatory T Cells
Foks, A. C., Lichtman, A. H., & Kuiper, J. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303568 · Cited by 201
Gambineri, E., Ciullini Mannurita, S., Hagin, D., Vignoli, M., Anover-Sombke, S., DeBoer, S., Segundo, G. R. S., Allenspach, E. J., Favre, C., Ochs, H. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02411 · Cited by 187
Salvany-Celades, M., van der Zwan, A., Benner, M., Setrajcic-Dragos, V., Bougleux Gomes, H. A., Iyer, V., Norwitz, E. R., Strominger, J. L., & Tilburgs, T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.109 · Cited by 174
Szurek, E., Cebula, A., Wojciech, L., Pietrzak, M., Rempala, G., Kisielow, P., & Ignatowicz, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141161 · Cited by 163
Miyara, M., Chader, D., Sage, E., Sugiyama, D., Nishikawa, H., Bouvry, D., Claër, L., Hingorani, R., Balderas, R., Rohrer, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508224112 · Cited by 157
FOXP3+ Treg Cells and Gender Bias in Autoimmune Diseases
Nie, J., Li, Y. Y., Zheng, S. G., Tsun, A., & Li, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00493 · Cited by 170
Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study
Shevach, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01048 · Cited by 150
IL-10–overexpressing B cells regulate innate and adaptive immune responses
Stanić, B., van de Veen, W., Wirz, O. F., Rückert, B., Morita, H., Söllner, S., Akdiş, C. A., & Akdis, M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.041 · Cited by 157
Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells
Hirakawa, M., Matos, T. R., Liu, H., Koreth, J., Kim, H. T., Paul, N. E., Murase, K., Whangbo, J., Alho, A. C., Nikiforow, S., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89278 · Cited by 151
Transcriptional regulation and development of regulatory T cells
Lee, W., & Lee, G. R. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.313 · Cited by 135
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface
Papúchová, H., Meissner, T. B., Li, Q., Strominger, J. L., & Tilburgs, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02730 · Cited by 154
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
Moody, M. A., Pedroza-Pacheco, I., Vandergrift, N. A., Chui, C., Lloyd, K. E., Parks, R., Soderberg, K. A., Ogbe, A. T., Cohen, M. S., Liao, H.-X., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag0851 · Cited by 128
Scurr, M., Ladell, K., Besneux, M., Christian, A., Hockey, T., Smart, K., Bridgeman, H., Hargest, R., Phillips, S., Davies, M., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.62 · Cited by 127
Impact of Immune-Modulatory Drugs on Regulatory T Cell
Furukawa, A., Wisel, S. A., & Tang, Q. (2016) · Transplantation · doi:10.1097/tp.0000000000001379 · Cited by 137
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity
Breuer, J., Schwab, N., Schneider‐Hohendorf, T., Marziniak, M., Mohan, H., Bhatia, U., Gross, C. C., Clausen, B. E., Weishaupt, C., Luger, T. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24165 · Cited by 124
Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Bin Dhuban, K., d’Hennezel, E., Nashi, E., Bar-Or, A., Rieder, S., Shevach, E. M., Nagata, S., & Piccirillo, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401803 · Cited by 117
“These findings are in agreement with, and extend, recently reported observations that inflammatory cytokine production in human FOXP3 cells is restricted to the Helios(2) population (10, 12, 33).”
ResultRegulatory T‐cell heterogeneity and the cancer immune response
Ward‐Hartstonge, K. A., & Kemp, R. A. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.43 · Cited by 122
Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells
Pandiyan, P., & Zhu, J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.005 · Cited by 120
Ito, S., Bollard, C. M., Carlsten, M., Melenhorst, J. J., Biancotto, A., Wang, E., Chen, J., Kotliarov, Y., Cheung, F., Xie, Z., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.50 · Cited by 117
The CD4-centered universe of human T cell subsets
Geginat, J., Paroni, M., Facciotti, F., Gruarin, P., Kastirr, I., Caprioli, F., Pagani, M., & Abrignani, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.012 · Cited by 144
Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells
Dijke, I. E., Hoeppli, R. E., Ellis, T., Pearcey, J., Huang, Q., McMurchy, A. N., Boer, K., Peeters, A. M. A., Aubert, G., Larsen, I., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13456 · Cited by 101
Self-citationHelios: still behind the clouds
Thornton, A. M., & Shevach, E. M. (2019) · Immunology · doi:10.1111/imm.13115 · Cited by 101
Molecular mechanisms underlying Th1-like Treg generation and function
Kitz, A., & Dominguez‐Villar, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2569-y · Cited by 104
Regulatory T cells for tolerance
Kawai, K., Uchiyama, M., Hester, J., Wood, K. J., & Issa, F. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.12.013 · Cited by 99
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Elkord, E., Abd Al Samid, M., & Chaudhary, B. (2015) · Oncotarget · doi:10.18632/oncotarget.4771 · Cited by 94
“While it is recognized that two distinct subsets of Helios+ and Helios− Tregs exist within FoxP3+ Tregs, their role and function are still subject to debate and Helios is currently not regarded as a definitive marker to differentiate between pTregs and tTregs [32].”
BackgroundThe Dual Role of Treg in Cancer
Frydrychowicz, M., Boruczkowski, M., Kolecka-Bednarczyk, A., & Dworacki, G. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12615 · Cited by 96
Helios is a marker, not a driver, of human Treg stability
Lam, A. J., Uday, P., Gillies, J. K., & Levings, M. K. (2022) · European Journal of Immunology · doi:10.1002/eji.202149318 · Cited by 92
Self-citationInduced regulatory T cells in inhibitory microenvironments created by cancer
Whiteside, T. L. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927432 · Cited by 90
Poirier, N., Dilek, N., Mary, C., Ville, S., Coulon, F., Branchereau, J., Tillou, X., Charpy, V., Pengam, S., Nerrière‐Daguin, V., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12964 · Cited by 91
Reparative T lymphocytes in organ injury
D’Alessio, F. R., Kurzhagen, J. T., & Rabb, H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124614 · Cited by 89
HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression
Yamamoto-Taguchi, N., Satou, Y., Miyazato, P., Ohshima, K., Nakagawa, M., Katagiri, K., Kinashi, T., & Matsuoka, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003630 · Cited by 88
Schaffert, H., Pelz, A., Saxena, A., Losen, M. H., Meisel, A., Thiel, A., & Köhler, S. (2015) · European Journal of Immunology · doi:10.1002/eji.201445064 · Cited by 87
Bjoern, J., Nitschke, N. J., Iversen, T. Z., Schmidt, H., Fode, K., & Svane, I. M. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1100788 · Cited by 90
Treg cell therapy: How cell heterogeneity can make the difference
Giganti, G., Atif, M., Mohseni, Y., Mastronicola, D., Grageda, N., Povoleri, G. A., Miyara, M., & Scottà, C. (2021) · European Journal of Immunology · doi:10.1002/eji.201948131 · Cited by 82
Peripheral and Thymic Foxp3+ Regulatory T Cells in Search of Origin, Distinction, and Function
Dhamne, C. A., Chung, Y., Alousi, A. M., Cooper, L. J. N., & Tran, D. Q. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00253 · Cited by 90
CD4 + FoxP3 + T regulatory cell subsets in myasthenia gravis patients
Köhler, S., Keil, T. O. P., Hoffmann, S., Swierzy, M., Ismail, M., Rückert, J. C., Alexander, T., & Meisel, A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.003 · Cited by 78
Vahidian, F., Duijf, P. H. G., Safarzadeh, E., Derakhshani, A., Baghbanzadeh, A., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.004 · Cited by 75
T Regulatory Cell Biology in Health and Disease
Alroqi, F. J., & Chatila, T. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0606-9 · Cited by 94
Hoeppli, R. E., MacDonald, K. N., Leclair, P., Fung, V. C. W., Mojibian, M., Gillies, J., Rahavi, S. M. R., Campbell, A. I. M., Gandhi, S. K., Pesenacker, A. M., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.14936 · Cited by 74
Self-citationRegulatory T cells in kidney disease and transplantation
Hu, M., Wang, Y. M., Wang, Y., Zhang, G. Y., Zheng, G., Yi, S., O’Connell, P. J., Harris, D. C. H., & Alexander, S. I. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.022 · Cited by 81
Hetemäki, I., Kaustio, M., Kinnunen, M., Heikkilä, N., Keskitalo, S., Nowlan, K., Miettinen, S., Sarkkinen, J., Glumoff, V., Andersson, N., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe3454 · Cited by 76
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis
Henderson, L. A., Hoyt, K. J., Lee, P. Y., Rao, D. A., Jonsson, A. H., Nguyen, J. P., Rutherford, K. D., Julé, A. M., Charbonnier, L., Case, S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132508 · Cited by 79
Zhang, Y., Jiang, X., Zhang, N., Chen, M., Wang, H., & Zhu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.017 · Cited by 91
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells
He, X., Landman, S., Bauland, S. C. G., van den Dolder, J., Koenen, H. J. P. M., & Joosten, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156311 · Cited by 69
Regulatory T Cell Subsets in Filarial Infection and Their Function
Metenou, S., & Nutman, T. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00305 · Cited by 67
Sun, L., Jin, H., & Li, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8753 · Cited by 79
Chen, Y., Efebera, Y. A., Johnston, L., Ball, E. D., Avigan, D., Lekakis, L. J., Bachier, C. R., Martin, P. J., Duramad, O., Ishii, Y., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.01.069 · Cited by 67
Raffin, C., Pignon, P., Celse, C., Debien, E., Valmori, D., & Ayyoub, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301378 · Cited by 63
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes
Uenishi, G. I., Repic, M., Yam, J. Y., Landuyt, A. E., Lakshmi, P. S., Guo, T., Zarin, P., Sassone‐Corsi, M., Chicoine, A. T., Kellogg, H., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.171844 · Cited by 72
Disrupted regulatory T cell homeostasis in inflammatory bowel diseases
Pedros, C., Duguet, F., Saoudi, A., & Chabod, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.974 · Cited by 69
Elkord, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00276 · Cited by 60
Dixit, N., Fanton, C. P., Langowski, J. L., Kirksey, Y. M., Kirk, P. B., Chang, T., Cetz, J., Dixit, V., Kim, G., Kuo, P., et al. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100103 · Cited by 62
Helios defines T cells being driven to tolerance in the periphery and thymus
Ross, E. M., Bourges, D., Hogan, T. V., Gleeson, P. A., & van Driel, I. R. (2014) · European Journal of Immunology · doi:10.1002/eji.201343999 · Cited by 56
Bouvy, A. P., Klepper, M., Kho, M. M. L., Boer, K., Betjes, M. G. H., Weimar, W., & Baan, C. C. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu079 · Cited by 59
CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection
Simonetta, F., & Bourgeois, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00215 · Cited by 57
Bjoern, J., Iversen, T. Z., Nitschke, N. J., Andersen, M. H., & Svane, I. M. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.05.010 · Cited by 55
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
Thomas, A. A., Fisher, J. L., Rahme, G. J., Hampton, T. H., Baron, U., Olek, S., Schwachula, T., Rhodes, C. H., Gui, J., Tafe, L. J., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou363 · Cited by 52
Ezzelarab, M. B., Zhang, H., Guo, H., Lu, L., Zahorchak, A. F., Wiseman, R. W., Nalesnik, M. A., Bhama, J. K., Cooper, D. K. C., & Thomson, A. W. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13685 · Cited by 51
Liver X receptor activation promotes differentiation of regulatory T cells
Herold, M. V. B., Breuer, J., Hucke, S., Knolle, P. A., Schwab, N., Wiendl, H., & Klotz, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184985 · Cited by 59
Mercer, F. K., Khaitan, A., Kozhaya, L., Aberg, J. A., & Unutmaz, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302936 · Cited by 50
Rabe, H., Nordström, I., Andersson, K. M., Lundell, A., & Rudin, A. (2014) · Immunology · doi:10.1111/imm.12209 · Cited by 51
Humoral autoimmunity: A failure of regulatory T cells?
Dhaeze, T., Stinissen, P., Liston, A., & Hellings, N. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.006 · Cited by 51
McPherson, S. W., Heuss, N. D., Pierson, M. J., & Gregerson, D. S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0205-4 · Cited by 52
Innate Control of Tissue-Reparative Human Regulatory T Cells
Lam, A. J., MacDonald, K. N., Pesenacker, A. M., Juvet, S. C., Morishita, K. A., Bressler, B., iGenoMed Consortium, Pan, J. G., Sidhu, S. S., Rioux, J. D., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801330 · Cited by 47
Self-citationLong, Y., Xia, C.-S., Xu, L., Liu, C., Fan, C., Bao, H., Zhao, X. T., & Liu, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00104 · Cited by 49
Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7
Silva, S. L., Albuquerque, A. S., Serra‐Caetano, A., Foxall, R. B., Pires, A. R., Matoso, P., Fernandes, S. M., Ferreira, J., Cheynier, R., Victorino, R. M. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7512 · Cited by 55
Julé, A. M., Hoyt, K. J., Wei, K., Gutiérrez‐Arcelus, M., Taylor, M. L., Ng, J., Lederer, J. A., Case, S., Chang, M. H., Cohen, E. M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149185 · Cited by 49
Helios—controller of Treg stability and function
Chougnet, C. A., & Hildeman, D. A. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.07.37 · Cited by 49
High Peripheral Blood Th17 Percent Associated with Poor Lung Function in Cystic Fibrosis
Mulcahy, E. M., Hudson, J. B., Beggs, S. A., Reid, D. W., Roddam, L. F., & Cooley, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120912 · Cited by 47
Ritter, M., Osei-Mensah, J., Debrah, L. B., Kwarteng, A., Mubarik, Y., Debrah, A. Y., Pfarr, K. M., Hoerauf, A. M., & Layland, L. E. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007436 · Cited by 45
The immune phenotype may relate to cancer development in kidney transplant recipients
Hope, C. M., Grace, B. S., Pilkington, K. R., Coates, P. T. H., Bergmann, I. P., & Carroll, R. P. (2014) · Kidney International · doi:10.1038/ki.2013.538 · Cited by 46
Amodio, D., Cotugno, N., Macchiarulo, G., Rocca, S., Dimopoulos, Y. P., Castrucci, M. R., Vito, R. D., Tucci, F. M., McDermott, A. B., Narpala, S., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701312 · Cited by 46
Regulatory Cells and Transplantation Tolerance
Cobbold, S. P., & Waldmann, H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015545 · Cited by 42
Human treg cells are characterized by low/negative CD6 expression
Santana, C. A. G., Tung, J. W., & Gulnik, S. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22513 · Cited by 42
Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features
Lehtimäki, S., & Lahesmaa, R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00294 · Cited by 45
Duurland, C. L., Brown, C. C., O’Shaughnessy, R. F. L., & Wedderburn, L. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00103 · Cited by 46
Adiponectin/AdipoR1 Axis Promotes IL-10 Release by Human Regulatory T Cells
Ramos‐Ramírez, P., Malmhäll, C., Tliba, O., Rådinger, M., & Bossios, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677550 · Cited by 43
Lei, H., Kuchenbecker, L., Streitz, M., Sawitzki, B., Vogt, K., Landwehr-Kenzel, S., Millward, J. M., Juelke, K., Babel, N., Neumann, A. U., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13315 · Cited by 40
Seng, A., Krausz, K. L., Pei, D., Koestler, D. C., Fischer, R. T., Yankee, T. M., & Markiewicz, M. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000965 · Cited by 42
Regulatory T Cells-Related Genes Are under DNA Methylation Influence
Piotrowska, M., Gliwiński, M., Trzonkowski, P., & Iwaszkiewicz‐Grześ, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137144 · Cited by 37
Lutter, L., van der Wal, M., Brand, E. C., Maschmeyer, P., Vastert, S. J., Mashreghi, M., van Loosdregt, J., & van Wijk, F. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1420 · Cited by 38
Scarlata, C., Celse, C., Pignon, P., Ayyoub, M., & Valmori, D. (2014) · European Journal of Immunology · doi:10.1002/eji.201444897 · Cited by 34
Zhang, H., Guo, H., Lu, L., Zahorchak, A. F., Wiseman, R. W., Raimondi, G., Cooper, D. K. C., Ezzelarab, M. B., & Thomson, A. W. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13113 · Cited by 33
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Nirmala, S. S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz‐Grześ, D., Piotrowska, M., Sakowska, J., Tomaszewicz, M., Morales, J. M. M., Lakshmi, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321228 · Cited by 45
Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer
Chaudhary, B., Samid, M. A. A., al-Ramadi, B. K., & Elkord, E. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.900539 · Cited by 35
Treg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla, R., Acevedo, D., Luo, Y., Esteve‐Solé, A., Vlagea, A. D., Correa‐Rocha, R., Seoane-Reula, E., & Alsina, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278759 · Cited by 38
Brezar, V., Ruffin, N., Richert, L. E., Surénaud, M., Lacabaratz, C., Palucka, K., Thiébaut, R., Banchereau, J., Lévy, Y., & Seddiki, N. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004752 · Cited by 31
Metadata
- Authors
- Himmel, M. E., MacDonald, K. G., Garcia, R. V., Steiner, T. S., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- Department of Surgery, Child and Family Research Institute, University of British Columbia , Vancouver, British Columbia V5Z 4H4,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 190
- Issue
- 5
- Pages
- 2001-2008
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2158966149
- Cited by
- 217
- References
- 42
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 13 · 2023: 6 · 2022: 6 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 7 · 2017: 18 · 2016: 30 · 2015: 33 · 2014: 35 · 2013: 19
- FWCI
- 21.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (IIN84037, 115199_1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- Helios, Foxp3+ regulatory T cells, naturally occurring regulatory T cells, induced regulatory T cells, Treg suppressive function, FOXP3 demethylation, CCL3, interferon-gamma, Th1 polarization, CD39, CTLA-4
- MeSH terms
- Apyrase, Cell Differentiation, Clone Cells, Flow Cytometry, Humans, Interferon-gamma, Organ Specificity, Thymus Gland, Antigens, CD, Gene Expression, Immunophenotyping, Cell Lineage, T-Lymphocytes, Regulatory, Ikaros Transcription Factor, Forkhead Transcription Factors, Chemokine CCL3, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.